These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2685081)
1. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. Hamer AW; Arkles LB; Johns JA J Am Coll Cardiol; 1989 Dec; 14(7):1768-74. PubMed ID: 2685081 [TBL] [Abstract][Full Text] [Related]
2. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890 [TBL] [Abstract][Full Text] [Related]
3. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Massie BM; Fisher SG; Radford M; Deedwania PC; Singh BN; Fletcher RD; Singh SN Circulation; 1996 Jun; 93(12):2128-34. PubMed ID: 8925581 [TBL] [Abstract][Full Text] [Related]
4. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Nicklas JM; McKenna WJ; Stewart RA; Mickelson JK; Das SK; Schork MA; Krikler SJ; Quain LA; Morady F; Pitt B Am Heart J; 1991 Oct; 122(4 Pt 1):1016-21. PubMed ID: 1927852 [TBL] [Abstract][Full Text] [Related]
5. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. Cleland JG; Dargie HJ; Findlay IN; Wilson JT Br Heart J; 1987 May; 57(5):436-45. PubMed ID: 3297121 [TBL] [Abstract][Full Text] [Related]
6. [Amiodarone in cardiac failure]. Barbosa Filho J; Barbosa PR; Soares JP Arq Bras Cardiol; 1993 Feb; 60(2):77-9. PubMed ID: 8240053 [TBL] [Abstract][Full Text] [Related]
7. Low-dose amiodarone in severe chronic heart failure. Biswas A; Dey SK; Banerjee AK; Roy S; Biswas PK; Chowdhury GK; Khan AK; Mitra KK; Chatterjee SS; Maity AK Indian Heart J; 1996; 48(4):361-4. PubMed ID: 8908821 [TBL] [Abstract][Full Text] [Related]
8. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Cairns JA; Connolly SJ; Roberts R; Gent M Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198 [TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone. Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193 [TBL] [Abstract][Full Text] [Related]
10. [Amiodarone in heart insufficiency]. Barbosa Filho J; Barbosa PR; Soares JP Rev Port Cardiol; 1992 Nov; 11(11):963-6. PubMed ID: 1290643 [TBL] [Abstract][Full Text] [Related]
11. Ventricular arrhythmias during exercise in patients with heart failure: the effect of amiodarone. Cleland JG; Dargie HJ Eur Heart J; 1987 Aug; 8 Suppl D():65-9. PubMed ID: 3678263 [TBL] [Abstract][Full Text] [Related]
12. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151 [TBL] [Abstract][Full Text] [Related]
13. Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity. Mahmarian JJ; Smart FW; Moyé LA; Young JB; Francis MJ; Kingry CL; Verani MS; Pratt CM Am J Cardiol; 1994 Oct; 74(7):681-6. PubMed ID: 7524296 [TBL] [Abstract][Full Text] [Related]
14. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH; J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258 [TBL] [Abstract][Full Text] [Related]
15. Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy. Singh SN; Fletcher RD Am J Cardiol; 1999 Nov; 84(9A):103R-108R. PubMed ID: 10568668 [TBL] [Abstract][Full Text] [Related]
16. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
17. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH; N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722 [TBL] [Abstract][Full Text] [Related]
18. Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone. De Paola AA; Horowitz LN; Spielman SR; Brady P; Morganroth J; Greenspan AM; Kay HR Am J Cardiol; 1987 Aug; 60(4):276-80. PubMed ID: 3303888 [TBL] [Abstract][Full Text] [Related]
19. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Doval HC; Nul DR; Grancelli HO; Perrone SV; Bortman GR; Curiel R Lancet; 1994 Aug; 344(8921):493-8. PubMed ID: 7914611 [TBL] [Abstract][Full Text] [Related]
20. Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators. Singh S; Fletcher RD; Fisher S; Deedwania P; Lewis D; Massie B; Singh B; Colling CL Control Clin Trials; 1992 Oct; 13(5):339-50. PubMed ID: 1385036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]